| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 55 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,009 | $148.06 | $149,396.69 | -7.2% | +2.9% | +74.5% | |
| Feb 16, 2024 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 7,030 | $148.06 | $1,040,884.56 | -4.8% | +2.9% | +74.5% | |
| Feb 2, 2024 | Franchini Indrani Lall56 | EVP, CLO &Secretary | Sale+OE | 1,591 | $170.99 | $272,050.04 | -11.6% | -13.1% | +56.8% | |
| Dec 27, 2023 | Bonney Michael W | Director | Sale+OE | 30,000 | $195.00 | $5,850,000.00 | -65.2% | -22.7% | +23.4% | |
| Aug 7, 2023 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 7,627 | $184.78 | $1,409,305.89 | -9.8% | -9.3% | +42.5% | |
| Aug 4, 2023 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 4,057 | $185.85 | $753,986.38 | -1.8% | -13.0% | +46.6% | |
| Aug 4, 2023 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 3,460 | $185.85 | $643,036.64 | -3.3% | -13.0% | +46.6% | |
| Aug 4, 2023 | Vaishnaw Akshay56 | President | Sell | 4,057 | $185.85 | $753,986.38 | -2.8% | -13.0% | +46.6% | |
| Aug 3, 2023 | Bonney Michael W | Director | Sale+OE | 6,448 | $185.38 | $1,195,310.07 | -4.6% | -17.4% | +43.1% | |
| Apr 28, 2023 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 4,294 | $197.12 | $846,449.96 | -5.8% | -2.2% | -28.1% |